Alivus Life Sciences Limited (BOM:543322)
India flag India · Delayed Price · Currency is INR
987.55
-12.45 (-1.25%)
At close: Apr 17, 2025

Alivus Life Sciences Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2018 - 2019
Market Capitalization
126,65495,16148,14156,215--
Upgrade
Market Cap Growth
49.68%97.67%-14.36%---
Upgrade
Enterprise Value
122,35190,91344,57052,405--
Upgrade
Last Close Price
1030.30775.30378.46410.94--
Upgrade
PE Ratio
28.6720.2110.3113.43--
Upgrade
PS Ratio
5.574.172.232.65--
Upgrade
PB Ratio
4.994.082.252.74--
Upgrade
P/TBV Ratio
5.024.112.272.75--
Upgrade
P/FCF Ratio
-33.4433.6212.08--
Upgrade
P/OCF Ratio
-23.0115.739.41--
Upgrade
EV/Sales Ratio
5.383.982.062.47--
Upgrade
EV/EBITDA Ratio
19.6113.596.978.53--
Upgrade
EV/EBIT Ratio
21.5514.617.429.05--
Upgrade
EV/FCF Ratio
-31.9531.1211.26--
Upgrade
Debt / Equity Ratio
0.010.010.010.001.242.64
Upgrade
Debt / EBITDA Ratio
0.030.030.030.001.572.24
Upgrade
Debt / FCF Ratio
-0.060.140.012.917.36
Upgrade
Asset Turnover
-0.820.840.951.010.96
Upgrade
Inventory Turnover
-1.641.872.072.021.76
Upgrade
Quick Ratio
-2.642.343.100.660.52
Upgrade
Current Ratio
-4.373.734.601.150.89
Upgrade
Return on Equity (ROE)
-21.07%22.28%29.83%60.91%127.84%
Upgrade
Return on Assets (ROA)
-14.01%14.52%16.20%18.86%17.33%
Upgrade
Return on Capital (ROIC)
14.30%17.26%17.82%19.34%22.32%20.46%
Upgrade
Return on Capital Employed (ROCE)
-25.80%27.20%27.70%72.40%106.10%
Upgrade
Earnings Yield
3.49%4.95%9.70%7.45%--
Upgrade
FCF Yield
-2.99%2.97%8.28%--
Upgrade
Dividend Yield
-2.90%5.55%5.11%--
Upgrade
Payout Ratio
-58.55%82.64%30.73%--
Upgrade
Buyback Yield / Dilution
-0.28%-0.13%-4.25%-9.03%--35.79%
Upgrade
Total Shareholder Return
-0.28%2.78%1.30%-3.91%--35.79%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.